Wearable heart monitors during cancer treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Injuries & trauma, Skin clinical trials.
This study tests whether a wearable heart monitor can help detect heart problems early in people receiving cancer treatment. It may help doctors manage heart health during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer, leukemia, lymphoma, or multiple myeloma.
- You are 18 years or older.
- You are willing to sign a consent form.
- You do not have an allergy to adhesive patches used for heart monitoring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a small, sticky heart-monitoring patch worn on the chest can safely and helpfully track vital signs (like heart rate) for people in their final days of life with cancer. The goal is to see if this technology helps caregivers and doctors better understand comfort and changes in condition.
This trial tests a new device that monitors heart health during cancer treatment. It uses a simple on-body sensor alongside your regular echocardiogram to see if it can detect heart changes early.
This trial is testing whether a lower radiation dose and a wearable heart monitor can reduce the risk of heart rhythm problems in people receiving chest radiation for cancer. It may help those at moderate-to-high risk of heart side effects from treatment.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This study helps doctors predict which cancer patients are at higher risk of heart problems from their cancer treatments. By tracking your heart health before, during, and after treatment, researchers can develop better ways to protect your heart.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
Hear when a new Cardiotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.